Shares

4 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q2 2022

Jul 22, 2022

SELL
$117.13 - $176.59 $8.85 Million - $13.3 Million
-75,515 Closed
0 $0
Q1 2022

Apr 21, 2022

BUY
$126.46 - $235.05 $2.01 Million - $3.73 Million
15,869 Added 26.61%
75,515 $13 Million
Q4 2021

Feb 08, 2022

BUY
$225.82 - $368.51 $293,114 - $478,325
1,298 Added 2.22%
59,646 $15.1 Million
Q3 2021

Oct 26, 2021

BUY
$221.9 - $484.47 $12.9 Million - $28.3 Million
58,348 New
58,348 $22.4 Million

Others Institutions Holding MRNA

About Moderna, Inc.


  • Ticker MRNA
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 391,200,000
  • Market Cap $15.8B
  • Description
  • Moderna, Inc., a biotechnology company, discovers, develops, and commercializes messenger RNA therapeutics and vaccines for the treatment of infectious diseases, immuno-oncology, rare diseases, cardiovascular diseases, and auto-immune diseases in the United States, Europe, and internationally. Its respiratory vaccines include COVID-19, flu, resp...
More about MRNA
Track This Portfolio

Track Artemis Investment Management LLP Portfolio

Follow Artemis Investment Management LLP and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Artemis Investment Management LLP, based on Form 13F filings with the SEC.

News

Stay updated on Artemis Investment Management LLP with notifications on news.